Skip to content

Observational study on the efficacy of autologous platelet-rich plasma intrauterine infusion combined with hysteroscopic adhesiolysis versus hysteroscopic adhesiolysis alone for the treatment of intrauterine adhesions

Observational study on the efficacy of autologous platelet-rich plasma intrauterine infusion combined with hysteroscopic adhesiolysis versus hysteroscopic adhesiolysis alone for the treatment of intrauterine adhesions

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092680
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-11-25
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrauterine adhesion

Interventions

control group (Intrauterine adhesion separation):None
experimental group (Autologous platelet-rich plasma and intrauterine adhesion separation):None

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients treated with intrauterine adhesion separation alone or combined with PRP; 2, moderate to severe IUA (AFS score =5); 3, have fertility requirements; 4, age between 20-40 years old; 5. Normal endocrine and ovulation functions 6, no fertility requirements, but the reduction of menstrual volume =50% or amenorrhea, considering uterine factors, has excluded other causes (such as central factors, decreased ovarian function, ovulation disorders, etc.) caused

Exclusion criteria

Exclusion criteria: 1. Contraindications for hysteroscopic surgery; 2, estrogen and progesterone treatment contraindications; 3, pregnancy contraindications; 4, have other uterine diseases, such as endometritis, severe adenomyopathy or submucosal myoma; 5. History of pelvic malignancy and radiotherapy; 6. Dysfunction of liver, kidney, heart, lung and other vital organs; 7. Clinical manifestations of blood diseases, such as platelet dysfunction or severe anemia; 8, there are other infertility factors, such as early-onset ovarian failure, polycystic ovarian syndrome or early-onset ovarian insufficiency; 9, inflammation of the reproductive organs, such as endometritis, vaginitis, acute or subacute cervicitis, acute and chronic pelvic inflammation, reproductive tract tuberculosis, sexually transmitted diseases, untreated and untreated; 10. Abnormal uterine bleeding did not exclude endometrial lesions; 11. Body temperature higher than 37.5 degrees

Design outcomes

Primary

MeasureTime frame
The decline of AFS and IUA scores and the rate of adhesion reconstruction were compared between the two groups.;

Secondary

MeasureTime frame
Changes of postoperative menstrual flow;Postoperative endometrial thickness changes;Clinical pregnancy rate;

Countries

China

Contacts

Public ContactHaiyan Hu

Shanghai Sixth People's Hospital

xuri1104@163.com+86 189 3017 4575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026